Microgen: peers
Microgen beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.
Microgen, MD Medical Group Investments, Human Stem Cells Institute Pjsc, Protek: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | Microgenbase 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Pharmacy Chain 36.6 APTK.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | MD Medical Group Investments MD6B.F · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Human Stem Cells Institute Pjsc ISKJ.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Pharmsynthez LIFE.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Diod Maker Of Eco-Friendly Equipment and Nutrition DIOD.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | International Medical Center Of Biomaterials Processing and Cryostorage Public Joint-Stock Company GEMA.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Protek PRTK.ME · 🇷🇺 RU Percentile in Healthcare Percentile in Russia | Group median |
|---|---|---|---|---|---|---|---|---|---|
| Size | |||||||||
| Market cap (Better neither way: ranked highest first) | —— | $661 MNov 19, 2026 · Market data2nd of 7 | $216 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one3rd of 7 | $113 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one4th of 7 | $9 MNov 19, 2026 · Market data6th of 7 | $9 MNov 19, 2026 · Market data7th of 7 | $15 MNov 19, 2026 · Market data5th of 7 | $846 Mlast known, Jan 1, 2020 · Market dataLast known value: no current one1st of 7 | $113 M7 ranked |
| Revenue (Better neither way: ranked highest first) | —— | —— | —— | —— | —— | —— | —— | $4.4 BFY2017 · Wikidataonly one with it | $4.4 B— |
| Net income (Higher is better) | —— | —— | —— | —— | —— | —— | —— | $101 MFY2017 · Wikidataonly one with it | $101 M— |
| Employees (Better neither way: ranked highest first) | 7,200as reported · Profile2nd of 2 | —— | —— | —— | —— | —— | —— | 12,0002012 · Profile1st of 2 | 9,6002 ranked |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Microgen: How market caps are worked out; Pharmacy Chain 36.6: Moscow Exchange, issue size times the close; MD Medical Group Investments: How market caps are worked out; Human Stem Cells Institute Pjsc: Moscow Exchange, issue size times the close; Pharmsynthez: Moscow Exchange, issue size times the close; Diod Maker Of Eco-Friendly Equipment and Nutrition: Moscow Exchange, issue size times the close; International Medical Center Of Biomaterials Processing and Cryostorage Public Joint-Stock Company: Moscow Exchange, issue size times the close; Protek: Moscow Exchange, issue size times the close.
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Fewer than two years of revenue are on file for these companies.
Rank in the group
Ranks need two fiscal years with the figure for at least two of these companies.
| Fiscal year | Microgen | Pharmacy Chain 36.6 | MD Medical Group Investments | Human Stem Cells Institute Pjsc | Pharmsynthez | Diod Maker Of Eco-Friendly Equipment and Nutrition | International Medical Center Of Biomaterials Processing and Cryostorage Public Joint-Stock Company | Protek |
|---|---|---|---|---|---|---|---|---|
| 2017 | — | — | — | — | — | — | — | $4.4 BWD |
Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.
Suggested peers of Microgen#
Companies of the same industry first, then the same sector, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- Pharmacy Chain 36.6APTK.ME · 🇷🇺 RussiaSame sector: Healthcare (Retail - Pharmacy) · Same country: RussiaMarket cap $661 M (Nov 19, 2026)40 of 100 (industry or sector 25 + country 15)In the group
- MD Medical Group InvestmentsMD6B.F · 🇷🇺 RussiaSame sector: Healthcare (Medical Care Facilities) · Same country: RussiaMarket cap $216 M (last known, Jul 30, 2023)40 of 100 (industry or sector 25 + country 15)In the group
- Human Stem Cells Institute PjscISKJ.ME · 🇷🇺 RussiaSame sector: Healthcare (Biotechnology) · Same country: RussiaMarket cap $113 M (last known, Jan 7, 2022)40 of 100 (industry or sector 25 + country 15)In the group
- PharmsynthezLIFE.ME · 🇷🇺 RussiaSame sector: Healthcare (Biotechnology) · Same country: RussiaMarket cap $9 M (Nov 19, 2026)40 of 100 (industry or sector 25 + country 15)In the group
- Diod Maker Of Eco-Friendly Equipment and NutritionDIOD.ME · 🇷🇺 RussiaSame sector: Healthcare (Pharmaceutical) · Same country: RussiaMarket cap $9 M (Nov 19, 2026)40 of 100 (industry or sector 25 + country 15)In the group
- International Medical Center Of Biomaterials Processing and Cryostorage Public Joint-Stock CompanyGEMA.ME · 🇷🇺 RussiaSame sector: Healthcare (Medical Care Facilities) · Same country: RussiaMarket cap $15 M (Nov 19, 2026)40 of 100 (industry or sector 25 + country 15)In the group
- ProtekPRTK.ME · 🇷🇺 RussiaSame sector: Healthcare · Same country: RussiaMarket cap $846 M (last known, Jan 1, 2020)40 of 100 (industry or sector 25 + country 15)In the group
- 40 of 100 (industry or sector 25 + country 15)+ Add
- 40 of 100 (industry or sector 25 + country 15)+ Add
- Richter Gedeon Vegyeszeti Gyar Nyilvanosan MukodoRIG2.F · 🇭🇺 HungarySame sector: Healthcare (Pharmaceutical) · Same region: Eastern EuropeMarket cap $7.6 B (Aug 1, 2026) · revenue $2.8 B (year to December 2025)32 of 100 (industry or sector 25 + country 7)+ Add
- Neuca S.A.NEU.WA · 🇵🇱 PolandSame sector: Healthcare (Retail - Pharmacy) · Same region: Eastern EuropeMarket cap $1.4 B (Nov 20, 2026) · revenue $2.5 B (year to December 2022)32 of 100 (industry or sector 25 + country 7)+ Add
- Ryvu Therapeutics S.A.RVU.WA · 🇵🇱 PolandSame sector: Healthcare (Biotechnology) · Same region: Eastern EuropeMarket cap $329 M (last known, Jan 5, 2024)32 of 100 (industry or sector 25 + country 7)+ Add
Any figure over the years, other peers or a saved group: open this group in the peer workspace.